E Fund Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Buy
+2,281
New +$607K 0.02% 253
2025
Q2
$532K Buy
3,870
+1,612
+71% +$237K 0.03% 221
2025
Q1
$407K Buy
2,258
+324
+17% +$54.5K 0.02% 247
2024
Q4
$303K Sell
1,934
-1,007
-34% -$179K 0.02% 312
2024
Q3
$535K Buy
2,941
+402
+16% +$77.5K 0.03% 187
2024
Q2
$466K Buy
2,539
+17
+0.7% +$2.85K 0.03% 182
2024
Q1
$449K Sell
2,522
-1,973
-44% -$274K 0.03% 174
2023
Q4
$558K Buy
4,495
+808
+22% +$89.6K 0.04% 138
2023
Q3
$428K Buy
3,687
+830
+29% +$101K 0.03% 153
2023
Q2
$335K Sell
2,857
-631
-18% -$64.4K 0.03% 203
2023
Q1
$279K Buy
3,488
+260
+8% +$20.4K 0.02% 238
2022
Q4
$256K Sell
3,228
-363
-10% -$26.9K 0.02% 256
2022
Q3
$250K Sell
3,591
-217
-6% -$15.7K 0.02% 264
2022
Q2
$250K Buy
3,808
+797
+26% +$49.6K 0.02% 263
2022
Q1
$200K Buy
+3,011
New +$188K 0.01% 298

Other funds holding KRYS